US2022056529A1PendingUtilityA1

Identification of pediatric onset inflammatory bowel disease loci and methods for use thereof for the diagnosis and treatment of the same

Assignee: CHILDRENS HOSPITAL PHILADELPHIAPriority: Feb 19, 2008Filed: Sep 3, 2021Published: Feb 24, 2022
Est. expiryFeb 19, 2028(~1.6 yrs left)· nominal 20-yr term from priority
C12Q 2600/172C12Q 1/6883C12Q 2600/158C12Q 2600/136C12Q 2600/156
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions and methods for the detection and treatment of inflammatory bowel disease are provided.

Claims

exact text as granted — not AI-modified
1 .- 12 . (canceled) 
     
     
         13 . A solid support comprising a nucleic acid comprising at least one inflammatory bowel disease (IBD)-associated single nucleotide polymorphism (SNP) selected from a Tat rs2315008 in the TNFRSF6B gene, an A at rs4809330 in the TNFRSF6B gene, and an A at rs2836878 in the PSMG1 gene. 
     
     
         14 .- 20 . (canceled) 
     
     
         21 . The solid support of  claim 13 , further comprising at least one additional IDB-associated SNP selected from the IBD-associated SNPs listed in Table 6A, Table 6B, Table 13, Table 14, Table 15, Table 16, Table 17, Table 18, and Table 19. 
     
     
         22 . The solid support of  claim 13 , wherein said IBD-associated SNP is associated with at least one of Chron's Disease (CD) and Ulcerative Colitis (UC). 
     
     
         23 . The solid support of  claim 13 , wherein said solid support includes microparticles, a microarray, the surface of a microtitration well or test tube, a biacore chip, a dipstick or a filter. 
     
     
         24 . The solid support of  claim 13 , wherein said solid support includes a microarray. 
     
     
         25 . The solid support of  claim 13 , wherein the solid support is made of polystryrene, cellulose, latex, nitrocellulose, nylon, polyacrylamide, dextran or agarose.

Join the waitlist — get patent alerts

Track US2022056529A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.